chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediate localized swelling, patient report of feeling sweaty and hot, then noted left arm felt cold, and felt it in his throat, later noteds "tasted it in his throat". Denied tongue swelling. He was given an injection of 0.3mg of Epinephrine 2 minutes after symptoms started, and 50mg IM Benadryl 3 minutes after the injection. His BP remained 130s-140s/90s, HR 90-99, O2 96-98% on room air. Patient was Alert and Oriented x 4, no tongue changes on exam, RRR no m/r/g and CTAB on cardiac and resp. exam. Hands felt cool to the touch and pale (bilatarally). He reported his hands and feet felt cold approx 10 minutes after the injection. The paramedics and ambulance arrived 18 minutes after the injection after which he was taken to the hospital
ANXIETY; MILD ACHES; FELT LIKE PINCHING IN THE ARMPIT  (FURTHER MENTIONED NOT IN THE ARMPIT AND MORE TOWARDS THE TOP PART OF THE SHOULDER ON THE LEFT SIDE); PULSATING FEELING (FELT BLOOD PUMPING FROM PALM UP TO ELBOW AND HIS SHOULDER AND THE CHEST) BUT ONLY ON THE LEFT SIDE; TIGHT MUSCLE FEELING IN THE CHEST, SHOULDER AND THE ARM ON THE LEFT SIDE; This spontaneous report received from a patient concerned a 45 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: asthma, penicillin allergy, seasonal allergies, alcohol use, and non-smoker, and other pre-existing medical conditions included: The patient had no drug abuse or illicit drug usage. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286, expiry: 21-OCT-2021) dose was not reported, administered on 04-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 04-SEP-2021, the patient experienced pulsating feeling (felt blood pumping from palm up to elbow and his shoulder and the chest) but only on the left side. On 04-SEP-2021, the patient experienced tight muscle feeling in the chest, shoulder and the arm on the left side. On 04-SEP-2021, the patient experienced mild aches. On 04-SEP-2021, the patient experienced felt like pinching in the armpit (further mentioned not in the armpit and more towards the top part of the shoulder on the left side). On 05-SEP-2021, the patient experienced anxiety. Treatment medications (dates unspecified) included: acetylsalicylic acid, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pulsating feeling (felt blood pumping from palm up to elbow and his shoulder and the chest) but only on the left side on 04-SEP-2021, was recovering from mild aches, and had not recovered from tight muscle feeling in the chest, shoulder and the arm on the left side, anxiety, and felt like pinching in the armpit (further mentioned not in the armpit and more towards the top part of the shoulder on the left side). This report was non-serious.
This spontaneous report was received from a registered nurse reporting that an unspecified amount of patients were administered on unspecified dates, improperly stored doses of (Oka/Merck) VARIVAX, from these possible lot #'s: (L013064, expiry date: 14-APR-2017), (L018001, expiry date, 19-MAY-2017), (L021215, expiry date, 10-JUN-2017), (L026410, expiry date, 15-FEB-2017), (L011083, expiry date, 01-APR-2017), and (L001335, expiry date, 13-JAN-2017). No adverse effects were reported. Additional information has been requested.
Rash, itching, fever. Vesicular lesions on thighs, chest, back and face.
little sore arm; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (little sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthmatic and Immunocompromised. Concomitant products included BUDESONIDE, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), FORMOTEROL FUMARATE, HYDROCHLOROTHIAZIDE, MELOXICAM, PANTOPRAZOLE, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), LOSARTAN POTASSIUM, AMLODIPINE BESILATE (AMLODIPINE BESYLATE), PROBIOTICS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little sore arm). At the time of the report, PAIN IN EXTREMITY (little sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jul-2021, Protein S: 1993 (abnormal) Abnormal. On 27-Oct-2021, Protein S: 1019 (abnormal) Abnormal. On 17-Jan-2022, Protein S: 197 (abnormal) Abnormal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was tested on 27-Jul-2021, then on 27-Oct-2021 and finally on 17-Jan-2022. In all N protein level was 0. No treatment was provided by the reporter.   This case was linked to MOD-2022-455714, MOD-2022-455738 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2022: Non significant follow up appended.
sleeps all the time; chest pain; pain behind left breast; still has not received the 2nd dose; headaches; low grade fever; tiredness/chronic fatigue; pain all over the body; vomiting; nausea; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleeps all the time), CHEST PAIN (chest pain), BREAST PAIN (pain behind left breast), PRODUCT DOSE OMISSION ISSUE (still has not received the 2nd dose) and HEADACHE (headaches) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia, Diverticulitis, Irritable bowel syndrome, Bladder irritability, Chronic fatigue syndrome, Osteoarthritis, Osteoporosis, Glaucoma, GERD, Hiatal hernia and Seasonal asthma (myocardial valve prolapse). Concomitant products included MONTELUKAST SODIUM (SINGULAIR) and ALBUTEROL [SALBUTAMOL] for Seasonal asthma, PREDNISONE, MORPHINE SULFATE, OXYCODONE, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), DICYCLOMINE [DICYCLOVERINE] and PARACETAMOL (TYLENOL) for an unknown indication.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (sleeps all the time), CHEST PAIN (chest pain), BREAST PAIN (pain behind left breast), PRODUCT DOSE OMISSION ISSUE (still has not received the 2nd dose), HEADACHE (headaches), PYREXIA (low grade fever), FATIGUE (tiredness/chronic fatigue), MYALGIA (pain all over the body), VOMITING (vomiting), NAUSEA (nausea) and FATIGUE (exhaustion). At the time of the report, SOMNOLENCE (sleeps all the time), HEADACHE (headaches), FATIGUE (tiredness/chronic fatigue) and MYALGIA (pain all over the body) had not resolved, CHEST PAIN (chest pain), BREAST PAIN (pain behind left breast), PRODUCT DOSE OMISSION ISSUE (still has not received the 2nd dose) and VOMITING (vomiting) had resolved, PYREXIA (low grade fever) and NAUSEA (nausea) outcome was unknown and FATIGUE (exhaustion) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's additional concomitant medication included steroids. The patient had medical history of myocardial valve prolapse.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow up received and added Patient's Other relevant history. Added Concomitant drugs. Added new events and events outcome updated.
Information has been received from a registered nurse referring to 3 or 4 patients of unknown demographics. On an unknown date the patients were vaccinated with PNEUMOVAX 23 injection (dose, route, frequency and lot # unspecified). Concomitant therapy was not reported. On an unknown date, patient experienced extreme pain that was debilitating and "achiness" described as "she had decrease range of motion in the shoulder joint of the upper arm area". Nurse reported the pain was localized to the general area in the shoulder joint of the upper arm. Nurse reported she rated the pain as a "10 out of 10". Nurse reported patients also had localized edema in an unspecified location. Nurse also reported that these 3 or 4 other patients who experienced the same symptoms as the patient in related case (MARRS#1506USA003505) after taking pneumococcal vaccine. The patient had sought medical attention and spoke to nurse. The outcome of joint range of motion decreased, asthenia, localised oedema and musculoskeletal pain was unknown. Causality assessment was not reported. This is one of several reports that received from the same reporter. Follow-up information has been received from the same reporter. Follow-up information has been received on 07-JUL-2015: All telephone attempts to obtain follow-up information have been unsuccessful. Follow up has been received from the registered nurse on 07-JUL-2015, refers to an adult female patient of unknown age (reported as greater than 60 years old). Reporting nurse stated that the patient received PNEUMOVAX 23 injection at his office. The patient experienced acute pain with limited range of motion at the injection site within hours of injection. Symptoms persisted for a duration of a couple of days. The patient was treated with ice, ibuprofen and slow range of motion on an unspecified date. She did not experienced any long term disability and recovered completely on an unspecified date. This is one of the two reports received from the same source (MARRS # 1506USA009447). Additional information has been requested. Event and narrative were updated.
covid vaccine breakthrough case  dose 1 Pfizer  1/20/21  EL3249 dose 2 Pfizer  2/10/21  EL9269
Symptomatic and Positive COVID-19 - cough, runny nose, fatigue
Felt like I had the flu for 3 days after the shot. I had a flu shot in the left arm at the same time, but no reaction to it (never had a previous reaction to flu shot for many years prior).  Had headache, body aches, feverish, and sore right bicep muscle.  Flu-like symptoms went away after 3 days, but  right bicep has large red sore area after 4 days.
My boys and I get the same dose and it's toxic; This is a spontaneous report from a contactable consumer. This consumer (patient's mother) reported for 16-year-old male patient (reporter's son). A 16-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date (age at vaccination 16-year-old) as dose 1, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller stated that she didn't want to get the full dose of 30 mcg shot because she felt weird after getting the first shot, she felt shaky and quavering inside. Her boys were small. The caller wanted to get the smaller dose for the second one instead of full 30 mcg. She thought it was too much and It was too toxic. She read that there were people having heart issues. She knew that there was a small risk but every day she was just reading stuff. It's toxic and they need a smaller dose. She read that it didn't take much to get an immune response. Caller stated that the vaccines were not only based on people's weight, but they were also based on people's age. She was a small person, and she was receiving the same dose her husband was 4x at. He had no side effects. Her boys and her got the same dose and it was toxic. It was a poison. The outcome of the event was unknown.  Information about Lot/batch number has been requested.
following vaccination patient c/o sudden HA with 3/10 pain level. Writer assessed patient.  Denies shortness of breath, denies tongue tingling/swelling.  Denies itching.  Denies nausea or symptoms of anaphylaxis.  Patient declined further medical attention offered.  VS 118/78, 88, 20, 98% RA. After waiting 30 minutes patient reports HA now 1/10  and she feels ok to leave site.
I cannot say for sure this was connected to the vaccine....but about a week afterwards both upper arm musles became sore as well as upper leg muscles, but it was tolerable. My brother who had the shot at same time had the same reaction but to a lesser degree. I waited to see if it would go away but it stayed. I then received my second dose on March 12 2021 and as the days went on it got worse to the point where I cannot get up and down from a chair without pushing my self up with my arms. WALKIBG BECAME MORE DIFFICULY, ESPECIALLY REGARDING STAIRS. i CONTINUED WAITING TO SEE IF IT WOULD FINALLY GO AWAY BUT AS IT REMAINED i FINALLY CONTACTED MY DOCTOR IN jULY AND TODAY i HAD A CONSULTATION WITH A NEUOROLOGIST AND HE WILL BE CONDUCTING A COUPLE OF PROCEDURES SOON REGARDING NERVES AND MUSCLES. (sorry for capital letters ... I pushed the wrong key) .. Again, I cannot be positive this was a reaction to the vaccine, but as I did not have this problem beforehand and as my brother had the same reaction to a much lesser degree, I thought I would report this as a friend encouraged me to. I am curious as to if any others that had the moderna vaccine have had this same experience. Thank you.
This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt as though I had COVID-19 again), BEDRIDDEN (didn't feel good for several days) and SOMNOLENCE (sleepy all day) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included COVID-19 from 25-Dec-2020 to 06-Jan-2021. Concomitant products included MULTIVITAMIN FOR WOMEN, CHONDROITIN SULFATE SODIUM, GLUCOSAMINE SULFATE POTASSIUM CHLORIDE, METHYLSULFONYLMETHANE (GLUCOSAMINE & CHONDROITIN & MSM) and EMERGEN C for an unknown indication. On 28-Jan-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced MALAISE (Felt as though I had COVID-19 again) and SOMNOLENCE (sleepy all day). 03-Mar-2021, the patient experienced BEDRIDDEN (didn't feel good for several days). On 07-Mar-2021, MALAISE (Felt as though I had COVID-19 again), BEDRIDDEN (didn't feel good for several days) and SOMNOLENCE (sleepy all day) had resolved. Treatment medication included Ibuprofen. This case was linked to MOD-2021-016297.
I woke up the next morning with numbness in my right forehead which later progressed to mild numbness in my right face. Later in the day, the soreness in my head worsened and extended back from my forehead to top of scalp on right side. I had ear pain which made it difficult to drink liquids as it caused more pain.  This morning, I do not have the ear pain. Still have mild numbness on the right side of my face and the scalp soreness is still there, but less. No facial or mouth drooping at all. Said in next statement that I have not recovered yet since I still have the numbness, although rather mild.
c/o fever 103 24hr p/vax;relief w/APAP;spike about 12hr later;also c/o h/a;fever spikes persisted x 4 days;highest temp 4 days p/vax was 105;MD was notified by parent via phone-was not seen by MD or treated;recv APAP for fever;
Pt developed Kawasaki disease on 10/12/2008. Admitted to hospital. Received ROTARIX on 9/29/2008.  11/21/08 Reviewed hospital medical records of 10/12-10/24/2008. FINAL DX: Kawasaki disease Records reveal patient experienced fever, cough, runny nose, vomiting x 4 days, transient rash & red conjunctiva initially subsided after 2 days.  Had been seen in ERon 10/9 & dx w/viral syndrome.  ID & cardiac consults done.  Tx w/IVIG & high dose ASA.  Improved & d/c to home on continued low dose ASA.
Grandmother informed staff that patient was 12 yeas old. After she was vaccinated, during documentation, her birthday was noted. when asked to verify the date of birth, patient stated her birthday however she continue to state that she was 12 years old. Grandmother was unable to verify her date of birth. She called the school to get verification . spoke with  teacher, who  stated what her birthday was documented as. Grandmother stated that she did not know when her birthday really is because she just received custody and was unsure. I have asked her to please fax over a copy of her birth certificate as soon as possible. Grandmother stated that she would send it as soon as possible.
Feels 20 years younger. She can stay on her treadmill longer; This is a spontaneous report from a non-contactable consumer (patient) via a sponsored program. A 72-year-old female patient received the second dose of BNT162B2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on an unspecified date, as single dose, for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient wanted to compliment the COVID-19 vaccine and stated, "Got second shot. Feels good. Feels 20 years younger. She can stay on her treadmill longer. It is a relief to see family again." The outcome of the event was unknown.  No follow-up attempts are possible. information about lot/batch number cannot be obtained.
Expired vaccine is stored and then administered; Dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine is stored and then administered) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine is stored and then administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine is stored and then administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Vaccine was placed in refrigerator on 29 Oct 2021. Vaccine did not undergo any temperature excursion.  No adverse events were reported. No treatment medications were reported.
12/21/2021 I had a CT because I was having intestinal issues. Then had intestine dilation surgery on March 3, 2022.
Significant pain in arm starting within 3 hours of injection gradually making arm unusable. Some bruising at injection site, was becoming better by Tuesday, 11/11/03. Then Wed (11/12) started becoming worse again until Friday (11/14) saw doctor. Doctor prescribed Vioxx 25 mg and pt says she has improved to where there is only small amount of pain when she moves arm a certain way.
Post vax, the pt developed redness and pain to right shoulder where tetanus shot was given.
Diarrhea; she had sore arm; This is a spontaneous report received from a contactable consumer (patient). A (age: 79; Units: unknown) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: not provided) via an unspecified route of administration on 15Feb2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that caller stated her first dose for Pfizer covid vaccine was on 15Feb2021. she had sore arm for 1 and a half days. She experienced Diarrhea started today, 4 days later (19Feb2021) from the first shot. caller wanted to know about it. Outcome of events was unknown.  Information about lot/ batch number has been requested. Follow-up attempts are completed. No further information is expected.
Information has been received from a physician concerning a 12 year old female who was vaccinated with the first dose of Gardasil. The patient experienced redness and swelling behind the injection site of the lower part of her tricep, closer to the elbow, after receiving the injection. Medical attention was sought. Additional information has been requested.
A 68 yr old male pharmacist reported that he experienced increased liver enzymes after receiving hep A vaccine inactivated (Havrix) and hep B vaccine recombinant (Engerix B) for prophylaxis. Concurrent medications included Atenol. In approx June 2003, the pt received his initial admin with Havrix prior to leaving the country. At an unspecified amount of time later, the pt received the second Havrix vaccination, and his initial admin of Engerix B. One month later he received his second Engerix B vaccination and on 19Dec03 received his third Engerix B vaccination. Approx 6 months after the initial Havrix vaccination, in Dec 2003, diagnostic examination revealed elevated liver enzymes (NOS). The event was unresolved at the time of reporting.
patient came by today and showed a red circular rash on her arm.  no itching, no difficulty breathing.  just warm to the touch.  she was feeling fine otherwise
Fever, chills, headache, confusion, injection limb pain, abdominal pain, diarrhea, night sweats. Symptoms continue to be present 6 days after injection.
Fever of 100°C; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100°C) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PYREXIA (Fever of 100°C). At the time of the report, PYREXIA (Fever of 100°C) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided